-
Berotralstat, sold
under the
brand name Orladeyo, is a
medication used to
prevent attacks of
hereditary angioedema (HAE) in
people aged
twelve years and...
- down the
merger in July. BioCryst’s core
development programs include:
Berotralstat (BCX7353), an oral
inhibitor of
plasma kallikrein for
prevention and...
- B06AC03
Ecallantide B06AC04
Conestat alfa B06AC05
Lanadelumab B06AC06
Berotralstat B06AX01
Crizanlizumab B06AX02
Betibeglogene autotemcel B06AX03 Voxelotor...
- for
prostate cancer.[citation needed] Ecallantide, lanadelumab, and
berotralstat are FDA-approved
drugs that
inhibit kallikrein and can be used for managing...
-
precursors and is
produced in
excess in
individuals with HAE
types I and II.
Berotralstat was
approved in the US in
December 2020, for the
prevention of attacks...
-
should be
avoided when prescribing.
Moderate CYP3A4
inhibitors such as
berotralstat, conivaptan, crizotinib, diltiazem, dronedarone, duvelisib, fedratinib...
